We are live on ! Find out more
GI

GS Investments Portfolio holdings

AUM $138M
1-Year Est. Return 27.72%
This Fund
S&P 500
This Quarter Est. Return
+9.35%
1 Year Est. Return
+27.72%
3 Year Est. Return
+94.06%
5 Year Est. Return
+114.86%
10 Year Est. Return
AUM
$207M
AUM Growth
+$15.9M
Cap. Flow
+$1.09M
Cap. Flow %
0.52%
Top 10 Hldgs %
35.79%
Holding
147
New
2
Increased
37
Reduced
38
Closed
3

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$600K
2
CRM icon
Salesforce
CRM
+$595K
3
AMT icon
American Tower
AMT
+$433K
4
MDT icon
Medtronic
MDT
+$424K
5
COP icon
ConocoPhillips
COP
+$383K

Top Sells

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$1.01M
2
NVDA icon
NVIDIA
NVDA
+$665K
3
HD icon
Home Depot
HD
+$269K
4
BABA icon
Alibaba
BABA
+$204K
5
NEAR icon
iShares Short Maturity Bond ETF
NEAR
+$51.3K

Sector Composition

Rank Sector Weight
1 Technology 23.22%
2 Financials 16.31%
3 Healthcare 13.45%
4 Consumer Discretionary 9.48%
5 Communication Services 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMT icon
26
Lockheed Martin
LMT
$135B
$3.07M 1.48%
8,642
+431
+5% +$149K
APD icon
27
Air Products & Chemicals
APD
$66.8B
$3.05M 1.47%
10,023
-4
-0% -$1.17K
DD icon
28
DuPont de Nemours
DD
$19.5B
$3.05M 1.47%
30,048
+6,302
+27% +$600K
PG icon
29
Procter & Gamble
PG
$342B
$2.69M 1.3%
16,441
+20
+0.1% +$2.97K
AMGN icon
30
Amgen
AMGN
$219B
$2.55M 1.23%
11,352
-90
-0.8% -$19K
HON icon
31
Honeywell
HON
$76.3B
$2.42M 1.17%
12,337
+54
+0.4% +$10.9K
CRM icon
32
Salesforce
CRM
$153B
$2.41M 1.17%
9,498
+2,119
+29% +$595K
INCY icon
33
Incyte
INCY
$24B
$2.4M 1.16%
32,750
BAC icon
34
Bank of America
BAC
$441B
$2.34M 1.13%
52,556
-40
-0.1% -$1.82K
BMY icon
35
Bristol-Myers Squibb
BMY
$131B
$2.3M 1.11%
36,817
-840
-2% -$49.3K
JPM icon
36
JPMorgan Chase
JPM
$947B
$2.29M 1.11%
14,438
+60
+0.4% +$9.85K
EQIX icon
37
Equinix
EQIX
$104B
$2.14M 1.04%
2,531
-22
-0.9% -$17.6K
WFC icon
38
Wells Fargo
WFC
$265B
$2.03M 0.98%
42,400
GOOG icon
39
Alphabet (Google) Class C
GOOG
$4.36T
$1.99M 0.96%
13,740
+20
+0.1% +$2.89K
STZ icon
40
Constellation Brands
STZ
$22.6B
$1.88M 0.91%
7,485
EFA icon
41
iShares MSCI EAFE ETF
EFA
$79.4B
$1.85M 0.89%
23,517
+7
+0% +$554
AMT icon
42
American Tower
AMT
$79.8B
$1.84M 0.89%
6,299
+1,586
+34% +$433K
ACN icon
43
Accenture
ACN
$105B
$1.62M 0.78%
3,900
-22
-0.6% -$8.02K
IJH icon
44
iShares Core S&P Mid-Cap ETF
IJH
$125B
$1.49M 0.72%
26,255
+220
+0.8% +$12.2K
TSN icon
45
Tyson Foods
TSN
$20.6B
$1.43M 0.69%
16,360
WSM icon
46
Williams-Sonoma
WSM
$29.1B
$1.36M 0.66%
16,142
+2,082
+15% +$194K
VCTR icon
47
Victory Capital Holdings
VCTR
$6.57B
$1.32M 0.64%
36,100
+9,400
+35% +$342K
BSCP
48
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$1.24M 0.6%
56,455
+2,660
+5% +$58.5K
BSCO
49
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$1.14M 0.55%
52,048
+2,665
+5% +$58.4K
COP icon
50
ConocoPhillips
COP
$140B
$1.11M 0.54%
15,423
+5,253
+52% +$383K

Similar funds

GS Investments's Q4 2021 Portfolio in Review

As of Q4 2021, GS Investments held 147 positions worth $207M, up 8.3% from $191M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 3.4%. GS Investments opened 2 new positions and exited 3, leaving the 147-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • GS Investments's largest Q4 2021 buy was Moderna: 48 shares worth $12K.
  • GS Investments added most to DuPont de Nemours in Q4 2021, an estimated $600K increase.
  • GS Investments's biggest Q4 2021 reduction was Texas Instruments, cutting an estimated $1.01M.
  • GS Investments fully exited AstraZeneca in Q4 2021, selling an estimated $6K.
  • GS Investments's ten largest holdings make up 36% of its $207M portfolio in Q4 2021.
  • GS Investments opened 2 new positions and closed 3 in Q4 2021.
  • GS Investments's portfolio value rose 8.3% quarter-over-quarter to $207M.

Based on GS Investments's 13F filing for Q4 2021, filed 9 Feb 2022.